Catalyst Wire Dossier Catalyst Wire Dossier

Hyperthermic Intraperitoneal Chemotherapy

HIPEC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Hyperthermic Intraperitoneal Chemotherapy, covering 2020-05-29 to 2022-02-18. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Neoadjuvant Hyperthermic Intraperitoneal Chemotherapy in Advanced High-grade Serous Ovarian Cancer (the NHIPEC Trial) [Phase 2]

See pricing